May 19, 2026
A 2017 request to create specific ICD-10 codes for electronic nicotine delivery systems (ENDS) was submitted to the ICD-10 Coordination and Maintenance Committee. It was met with inaction. Meanwhile, hospitalizations for e-cigarette or vaping product use‑associated lung injury (EVALI) surged across the United States, particularly among adolescents and young adults, creating a public health emergency.
Only after the crisis peaked did the World Health Organization introduce a dedicated diagnosis code——U07.0, Vaping‑related disorder——which the CDC implemented in the U.S. on April 1, 2020. The code arrived late, but for today‘s mental health clinician, the coding landscape for vaping remains fragmented. There is still no specific code for nicotine vaping dependence. There is no dedicated code for cannabis vaping. And the existing tools require careful clinical judgment to use accurately.
This article examines the ICD‑10 framework for documenting vaping use in mental health practice—from the acute pulmonary crisis to the chronic behavioral dependence. It clarifies the distinction between U07.0 and the nicotine dependence codes (F17.29‑), addresses the problem of “non‑nicotine” vaping, and offers practical guidance for documentation, risk management, and reimbursement.
U07.0: The Crisis Code That Arrived Too Late
The primary ICD‑10‑CM code for acute health conditions related to vaping is U07.0 (Vaping‑related disorder) . This billable/specific code, effective from October 1, 2025, for the 2026 edition, falls within the U00‑U85 range for “Codes for special purposes”.
U07.0 is explicitly designated for EVALI (e‑cigarette or vaping product use‑associated lung injury), a serious inflammatory lung condition that can be acute or subacute, with symptoms including coughing, shortness of breath, chest pain, fever, vomiting, and even death. The code also applies to “dabbing related lung damage/injury” and “electronic cigarette related lung damage/injury”.
When a patient presents with a vaping‑related condition, U07.0 must be assigned as the principal diagnosis. Additional codes are permitted for specific manifestations: acute respiratory failure (J96.0‑), pneumonitis (J68.0), abdominal pain (R10.84), diarrhea (R19.7), lipoid pneumonia (J69.1), or weight loss (R63.4). Respiratory signs such as cough or shortness of breath are not coded separately once a definitive vaping‑related diagnosis has been established. Gastrointestinal symptoms, however, may be coded separately.
Toxic effect coding: In cases where poisoning by inhalation of e‑liquid chemicals is the primary issue, a toxic effect code from the T51‑T65 range may be appropriate (e.g., T59.891A for accidental inhalation of other gases, fumes, and vapors). However, for a confirmed EVALI diagnosis, U07.0 remains the correct code.
A key clinical distinction: U07.0 is for acute physical illness caused by vaping. It is not a code for behavioral dependence. That distinction is critical for coding accuracy and reimbursement.
F17.29‑: Coding for Nicotine Vaping Dependence
For the far more common clinical scenario—a patient who vapes daily, reports cravings, cannot cut back, and experiences withdrawal symptoms on cessation—the appropriate code is drawn from the F17.29‑ family of nicotine dependence, other tobacco product.
Multiple authoritative sources confirm that electronic cigarettes (vaping devices) fall under “other tobacco products” for coding purposes. AAPC’s Coding Clinic (2017, Volume 4, Number 2) directs users to assign F17.290 (Nicotine dependence, other tobacco product, uncomplicated) for e‑cigarette use. This was reinforced in a 2025 AAPC blog, which noted that there are still no dedicated vaping dependence codes, so clinicians should continue to use the F17.29‑ series.
Available Subcodes within F17.29‑
The F17.2‑ series includes codes for various forms of nicotine dependence. For electronic cigarettes, the most relevant subcategory is F17.29‑ (Nicotine dependence, other tobacco product) , applicable to e‑cigarettes, cigars, pipe tobacco, hookahs, and similar products. Specific options include:
F17.290 – Nicotine dependence, other tobacco product, uncomplicated
F17.291 – Nicotine dependence, other tobacco product, in remission
F17.293 – Nicotine dependence, other tobacco product, with withdrawal
F17.298 – Nicotine dependence, other tobacco product, with other nicotine‑induced disorders
F17.299 – Nicotine dependence, other tobacco product, with unspecified nicotine‑induced disorders
The “uncomplicated” code (F17.290) requires documentation that the patient has no other nicotine‑induced disorders or complications.
According to ICD‑10 coding guidelines, a secondary code from category F17 should also be assigned to identify the type of nicotine dependence when the primary diagnosis is a related condition.
For patients vaping cannabis (THC) cartridges: No specific code for cannabis vaping dependence yet exists. Clinicians currently must rely on cannabis use disorder codes (F12.‑) to capture the underlying substance use disorder (SUD), with the route of administration documented narratively.
Excludes Notes for F17
ICD‑10 contains important excludes notes to prevent coding errors. A Type 1 Excludes note under F17 indicates that history of tobacco dependence (Z87.891), tobacco use NOS (Z72.0), and tobacco dependence should not be coded alongside current nicotine dependence. A Type 2 Excludes note permits separate coding of tobacco use during pregnancy (O99.33‑) alongside nicotine dependence.
Z72.0 and Z87.891: Ancillary Codes for the Clinical Record
Two additional codes help capture the patient‘s tobacco use status and history without indicating current dependence.
Z72.0 (Tobacco use, NOS – not otherwise specified) documents current tobacco use when dependence criteria are not met or when the patient simply uses tobacco without meeting a formal diagnosis of nicotine dependence. A Type 1 Excludes note under F17 explicitly excludes Z72.0, meaning the two codes cannot be used together.
Z87.891 (Personal history of nicotine dependence) is used when a patient has a past history of nicotine dependence but is not currently using nicotine and does not meet criteria for current dependence. This code has a Type 1 Excludes note indicating it cannot be used with current nicotine dependence (F17.2‑).
A Practical Documentation Strategy
When a patient who vapes presents for mental health treatment——whether for anxiety, depression, or substance use—the documentation should answer three coding questions:
Does the patient meet criteria for nicotine dependence? Assess for tolerance, withdrawal, loss of control, unsuccessful quit attempts, and continued use despite harm. If yes, assign the appropriate F17.29‑ code. If the patient uses nicotine but does not meet full dependence criteria, consider Z72.0.
Does the patient have a history of vaping‑related lung injury or EVALI? If the patient has a documented history of vaping‑induced pulmonary illness——even if resolved——and is being treated for ongoing respiratory concerns, U07.0 remains appropriate.
Is the patient using THC cartridges or other substances in their vaping device? If the patient is vaping cannabis, code the underlying SUD as F12.‑, and document the route of administration in the clinical narrative.
When to code both vaping and another SUD: If a patient uses multiple substances, each SUD should be coded separately. The clinical note must clearly distinguish the contribution of each substance to the patient‘s presentation.
Tips for Medical Coders
Official coding guidance emphasizes:
Distinguish between forms of nicotine dependence (cigarettes, smokeless, other). For electronic cigarettes, use F17.290‑F17.299.
Use F17.290 only for uncomplicated cases involving other tobacco product dependence, not for cigarettes or smokeless tobacco.
When EVALI is confirmed, assign U07.0 as the principal diagnosis, with additional codes for manifestations (respiratory failure, pneumonitis, etc.) as appropriate.
Do not code associated respiratory signs and symptoms separately once a definitive vaping‑related diagnosis has been established. However, gastrointestinal symptoms may be coded separately.
For toxic effects of e‑liquids without EVALI, codes from T51‑T65 (e.g., T59.891A) may be appropriate, with the intent specified by the 5th or 6th character.
The Clinical Context: Why Vaping Use Matters in Mental Health
Vaping is not a neutral behavior. Nicotine is delivered via the pulmonary route, producing a rapid, high‑magnitude “bolus” effect that confers higher addiction potential relative to slower nicotine delivery methods. For the mental health clinician, this means that patients who vape may have more intense cravings, more severe withdrawal, and greater difficulty achieving abstinence than patients who use other nicotine delivery systems.
Adolescents and young adults are disproportionately affected. E‑cigarettes have been the most commonly used tobacco product among U.S. middle and high school students since 2014. The rate of vaping‑related disorder diagnoses nearly doubled between 2020 and 2023, increasing 83% overall, with the 18–24 age group seeing a 52% increase.
Documenting vaping use in the clinical record is not merely a coding exercise. It is a clinical duty. The presence of nicotine dependence affects medication prescribing (e.g., CYP1A2 induction by smoking is less relevant for vaping, but nicotine itself still impacts metabolism, anxiety, and sleep). It influences risk assessment for cardiovascular and pulmonary disease. And it shapes treatment planning for substance use, anxiety, and mood disorders.
A patient‘s vaping history should be documented as part of every comprehensive biopsychosocial assessment. The code you assign tells the story of that history——whether it is a current dependence (F17.290), a past history (Z87.891), or a resolved pulmonary injury (U07.0).
FAQ
What is the ICD‑10 code for nicotine vaping dependence?
There is currently no specific code for vaping dependence. The correct codes are F17.290 (Nicotine dependence, other tobacco product, uncomplicated) for current dependence, F17.291 for dependence in remission, and F17.293 for dependence with withdrawal. These codes apply to electronic cigarettes and other ENDS devices.
What is the difference between U07.0 and F17.290?
U07.0 (Vaping‑related disorder) is for acute physical illness caused by vaping, particularly EVALI (e‑cigarette or vaping product use‑associated lung injury). F17.290 is for nicotine dependence on e‑cigarettes as a behavioral health condition. The two codes address different clinical problems and can be used together when a patient has both a current dependence and a history of vaping‑related lung injury.
How should I code a patient who vapes cannabis (THC) oil?
There is no specific ICD‑10 code for cannabis vaping dependence. Use the appropriate cannabis use disorder code from F12.‑ (e.g., F12.20 for uncomplicated dependence). Document in the clinical narrative that the patient‘s route of administration is vaping.
Can I use Z72.0 (Tobacco use NOS) for a patient who vapes but does not meet dependence criteria?
Yes. Z72.0 is appropriate for patients who currently use tobacco products——including e‑cigarettes——but do not meet formal criteria for nicotine dependence. This code is a Type 1 Excludes under F17, meaning it cannot be used together with a nicotine dependence code.
What documentation is required to support U07.0?
Documentation must establish a clear link between the patient‘s symptoms (respiratory distress, cough, chest pain, fever, gastrointestinal symptoms) and vaping use. The clinical note should include the timeline of vaping relative to symptom onset, results of any pulmonary or laboratory testing (e.g., CT chest, bronchoscopy, toxicology), and the absence of alternative explanations for the respiratory illness.
Conclusion
Vaping has outpaced the coding system designed to track it. U07.0 was born from a public health crisis, but it does not address the routine clinical reality of a patient who vapes daily, craves nicotine, struggles to quit, and seeks mental health treatment for anxiety, depression, or substance use. For those patients, the path leads through F17.290 and its subcodes, with Z72.0 and Z87.891 as supporting players.
The code you assign is not merely a billing necessity; it is a clinical statement. It tells the next provider whether the patient has a current dependence, a past history of injury, or an ongoing pulmonary condition. It shapes treatment decisions, risk assessments, and reimbursement. And, for now, it is the best tool we have to document a public health crisis that arrived faster than the codes designed to capture it.
References
AHA Coding Clinic® for ICD‑10‑CM and ICD‑10‑PCS. (n.d.). U07.0 Vaping‑related disorder – Official documentation guidelines.
ICD‑10 Data. (2026). 2026 ICD‑10‑CM Diagnosis Code U07.0 – Vaping‑related disorder.AAPC Knowledge Center. (2025, March 1). Vaping: An epidemic that lacks diagnosis codes.
ICD‑10 Data. (2026). 2026 ICD‑10‑CM Diagnosis Code F17 – Nicotine dependence (range and guidelines).
If you’re ready to spend less time on documentation and more on therapy, get started with a free trial today
Not medical advice. For informational use only.
Outline
More articles
